Cargando…
2-deoxy-D-glucose as India’s Response to COVID-19: A Commitment or Conceit?
2-deoxy-d-glucose (2-DG) has recently been approved for the treatment of moderate to severe COVID-19 patients in India. Here we discuss whether this is a well-thought-out step towards the long-term management of COVID-19 or a decision taken at the spur of the moment. 2-DG, an anticancer drug, also h...
| Autores principales: | , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Greater Baltimore Medical Center
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9195081/ https://www.ncbi.nlm.nih.gov/pubmed/35711390 http://dx.doi.org/10.55729/2000-9666.1052 |